Most Clicked StoriesMore >


PCMA: DIR reduces prescription drug costs

PCMA SmartBrief | Feb 15, 2017

Direct and indirect remuneration (DIR) reduces drug costs, says Pharmaceutical Care Management Association President and CEO Mark Merritt. "Those who know what they [DIR fees] really are understand that they save money for consumers, but sometimes people who have to pay these discounts and rebates don't want to pay them because they reduce their profit margin -- that's why they're fighting them," Merritt said. Specialty Pharmacy Times (02/14)


PCMA campaign shows how PBMs reduce Rx costs

PCMA SmartBrief | Feb 13, 2017

CMS nominee: "Thankful" for PBMs in Medicare Part D

PCMA SmartBrief | Feb 17, 2017

DIR fees reduce costs for taxpayers, Medicare beneficiaries

PCMA SmartBrief | Feb 13, 2017

Prime Therapeutics' clients saw low inflation last year

PCMA SmartBrief | Feb 17, 2017

Marathon puts the brakes on DMD drug as lawmakers launch probe

PCMA SmartBrief | Feb 14, 2017

Aetna, Humana abandon plan to merge

PCMA SmartBrief | Feb 14, 2017

Express Scripts CEO sets the record straight on drug prices

PCMA SmartBrief | Feb 17, 2017

What is drug price transparency?

PCMA SmartBrief | Feb 14, 2017

Drug execs not cheering Trump's push for radical change at FDA

PCMA SmartBrief | Feb 15, 2017


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more